MG
AGN

Meritage Group’s Allergan plc AGN Stock Holding History

Meritage Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,709
Closed -$989K – 81
2016
Q4 		$989K Sell
4,709
-548,802
-99% -$114M 0.03% 77
2016
Q3 		$127M Sell
553,511
-222,268
-29% -$54.3M 3.34% 15
2016
Q2 		$179M Buy
775,779
+66,744
+9% +$15.4M 4.66% 8
2016
Q1 		$190M Buy
709,035
+172,234
+32% +$49.3M 4.29% 8
2015
Q4 		$168M Buy
+536,801
New +$160M 4.19% 11

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Meritage Group's AGN Position: Q1 2017 in Review

Meritage Group sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 4,709 shares — an estimated $989K sold.

Meritage Group first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $190M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Meritage Group reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Meritage Group sold 4,709 Allergan plc shares in Q1 2017, an estimated $989K.
  • Meritage Group first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
  • Meritage Group's Allergan plc position peaked at $190M in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Meritage Group's 13F filing for Q1 2017, filed 12 May 2017.